“hair laser removal”的搜索结果，显示 1041-1050 项，共有 9124 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Also want to find out if kidney tumor treatment leads to an improvement in these immune markers. Phase 2 Trial Of Voyager V1 In Combination With Cemiplimab In ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This research is being done to evaluate the safety and tolerability of the new drug, axatilimab, in combination with olaparib (a standard of care treatment) ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This study aims to identify candidate High Grade Serous Cancer (HGSC) early detection and chemotherapy treatment response biomarkers. For the purpose of this ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... treatment at the recommended dose. A separate Phase 1 cohort will assess the ... treatment variables. The target of 2,500 patients is meant to ensure ...

5. 外科 - 临床试验- 妙佑医疗国际

   The purpose of this study is to further characterize the serum and Cerebral Spinal Fluid (CSF) biomarker profile of idiopathic normal pressure hydrocephalus ...

6. 皮肤科- 临床试验- 妙佑医疗国际

   This project will investigate whether the analysis of nucleic acids circulating in the blood from tumors can allow real-time monitoring of treatment response to ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... treatment at the recommended dose. A separate Phase 1 cohort will assess the ... treatment variables. The target of 2,500 patients is meant to ensure ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This study aims to identify candidate High Grade Serous Cancer (HGSC) early detection and chemotherapy treatment response biomarkers. For the purpose of this ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... treatment. Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer cells that express CD22 and kill ...